vs
Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and ENTEGRIS INC (ENTG). Click either name above to swap in a different company.
ENTEGRIS INC is the larger business by last-quarter revenue ($823.9M vs $487.7M, roughly 1.7× CLOVER HEALTH INVESTMENTS, CORP.). ENTEGRIS INC runs the higher net margin — 6.0% vs -10.1%, a 16.1% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs -3.1%). ENTEGRIS INC produced more free cash flow last quarter ($134.0M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 3.4%).
Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.
Entegris, Inc. is a supplier of materials for the semiconductor and other high-tech industries. Entegris has approximately 8,000 employees throughout its global operations. It has manufacturing, customer service and/or research facilities in the United States, Canada, China, Germany, Israel, Japan, Malaysia, Singapore, South Korea, and Taiwan. The company’s corporate headquarters are in Billerica, Massachusetts.
CLOV vs ENTG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $487.7M | $823.9M |
| Net Profit | $-49.3M | $49.4M |
| Gross Margin | — | 43.8% |
| Operating Margin | -10.1% | 12.7% |
| Net Margin | -10.1% | 6.0% |
| Revenue YoY | 44.7% | -3.1% |
| Net Profit YoY | -123.2% | -51.7% |
| EPS (diluted) | — | $0.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $487.7M | $823.9M | ||
| Q3 25 | $496.6M | $807.1M | ||
| Q2 25 | $477.6M | $792.4M | ||
| Q1 25 | $462.3M | $773.2M | ||
| Q4 24 | $337.0M | $849.8M | ||
| Q3 24 | $331.0M | $807.7M | ||
| Q2 24 | $356.3M | $812.7M | ||
| Q1 24 | $346.9M | $771.0M |
| Q4 25 | $-49.3M | $49.4M | ||
| Q3 25 | $-24.4M | $70.5M | ||
| Q2 25 | $-10.6M | $52.8M | ||
| Q1 25 | $-1.3M | $62.9M | ||
| Q4 24 | $-22.1M | $102.2M | ||
| Q3 24 | $-9.2M | $77.6M | ||
| Q2 24 | $7.4M | $67.7M | ||
| Q1 24 | $-19.2M | $45.3M |
| Q4 25 | — | 43.8% | ||
| Q3 25 | — | 43.5% | ||
| Q2 25 | — | 44.4% | ||
| Q1 25 | — | 46.1% | ||
| Q4 24 | — | 45.6% | ||
| Q3 24 | 24.5% | 46.0% | ||
| Q2 24 | 30.3% | 46.2% | ||
| Q1 24 | 23.6% | 45.6% |
| Q4 25 | -10.1% | 12.7% | ||
| Q3 25 | -4.9% | 15.2% | ||
| Q2 25 | -2.2% | 13.4% | ||
| Q1 25 | -0.3% | 15.8% | ||
| Q4 24 | -6.4% | 17.6% | ||
| Q3 24 | -2.7% | 16.9% | ||
| Q2 24 | 2.0% | 16.0% | ||
| Q1 24 | -6.5% | 15.3% |
| Q4 25 | -10.1% | 6.0% | ||
| Q3 25 | -4.9% | 8.7% | ||
| Q2 25 | -2.2% | 6.7% | ||
| Q1 25 | -0.3% | 8.1% | ||
| Q4 24 | -6.6% | 12.0% | ||
| Q3 24 | -2.8% | 9.6% | ||
| Q2 24 | 2.1% | 8.3% | ||
| Q1 24 | -5.5% | 5.9% |
| Q4 25 | — | $0.33 | ||
| Q3 25 | — | $0.46 | ||
| Q2 25 | — | $0.35 | ||
| Q1 25 | — | $0.41 | ||
| Q4 24 | — | $0.67 | ||
| Q3 24 | — | $0.51 | ||
| Q2 24 | — | $0.45 | ||
| Q1 24 | — | $0.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $78.3M | $360.4M |
| Total DebtLower is stronger | — | $3.7B |
| Stockholders' EquityBook value | $308.7M | $4.0B |
| Total Assets | $541.0M | $8.4B |
| Debt / EquityLower = less leverage | — | 0.94× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $78.3M | $360.4M | ||
| Q3 25 | — | $399.8M | ||
| Q2 25 | — | $376.8M | ||
| Q1 25 | — | $340.9M | ||
| Q4 24 | $194.5M | $329.2M | ||
| Q3 24 | $288.0M | $432.1M | ||
| Q2 24 | $254.8M | $320.0M | ||
| Q1 24 | $208.3M | $340.7M |
| Q4 25 | — | $3.7B | ||
| Q3 25 | — | $3.8B | ||
| Q2 25 | — | $4.0B | ||
| Q1 25 | — | $4.0B | ||
| Q4 24 | — | $4.0B | ||
| Q3 24 | — | $4.1B | ||
| Q2 24 | — | $4.1B | ||
| Q1 24 | — | $4.2B |
| Q4 25 | $308.7M | $4.0B | ||
| Q3 25 | $340.9M | $3.9B | ||
| Q2 25 | $344.2M | $3.8B | ||
| Q1 25 | $336.1M | $3.7B | ||
| Q4 24 | $341.1M | $3.7B | ||
| Q3 24 | $342.2M | $3.6B | ||
| Q2 24 | $324.9M | $3.5B | ||
| Q1 24 | $292.5M | $3.4B |
| Q4 25 | $541.0M | $8.4B | ||
| Q3 25 | $559.7M | $8.4B | ||
| Q2 25 | $575.0M | $8.4B | ||
| Q1 25 | $583.7M | $8.4B | ||
| Q4 24 | $580.7M | $8.4B | ||
| Q3 24 | $653.0M | $8.5B | ||
| Q2 24 | $674.2M | $8.3B | ||
| Q1 24 | $671.8M | $8.4B |
| Q4 25 | — | 0.94× | ||
| Q3 25 | — | 0.99× | ||
| Q2 25 | — | 1.05× | ||
| Q1 25 | — | 1.06× | ||
| Q4 24 | — | 1.08× | ||
| Q3 24 | — | 1.15× | ||
| Q2 24 | — | 1.18× | ||
| Q1 24 | — | 1.22× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-66.9M | $192.0M |
| Free Cash FlowOCF − Capex | $-69.0M | $134.0M |
| FCF MarginFCF / Revenue | -14.1% | 16.3% |
| Capex IntensityCapex / Revenue | 0.4% | 7.0% |
| Cash ConversionOCF / Net Profit | — | 3.89× |
| TTM Free Cash FlowTrailing 4 quarters | $-69.2M | $396.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-66.9M | $192.0M | ||
| Q3 25 | $12.1M | $249.5M | ||
| Q2 25 | $5.4M | $113.5M | ||
| Q1 25 | $-16.3M | $140.4M | ||
| Q4 24 | $34.8M | $176.1M | ||
| Q3 24 | $50.0M | $197.2M | ||
| Q2 24 | $44.8M | $111.2M | ||
| Q1 24 | $25.9M | $147.2M |
| Q4 25 | $-69.0M | $134.0M | ||
| Q3 25 | $11.4M | $182.8M | ||
| Q2 25 | $4.8M | $47.0M | ||
| Q1 25 | $-16.5M | $32.4M | ||
| Q4 24 | $33.3M | $68.6M | ||
| Q3 24 | $49.6M | $115.0M | ||
| Q2 24 | $44.4M | $51.9M | ||
| Q1 24 | $25.5M | $80.6M |
| Q4 25 | -14.1% | 16.3% | ||
| Q3 25 | 2.3% | 22.6% | ||
| Q2 25 | 1.0% | 5.9% | ||
| Q1 25 | -3.6% | 4.2% | ||
| Q4 24 | 9.9% | 8.1% | ||
| Q3 24 | 15.0% | 14.2% | ||
| Q2 24 | 12.5% | 6.4% | ||
| Q1 24 | 7.3% | 10.4% |
| Q4 25 | 0.4% | 7.0% | ||
| Q3 25 | 0.1% | 8.3% | ||
| Q2 25 | 0.1% | 8.4% | ||
| Q1 25 | 0.0% | 14.0% | ||
| Q4 24 | 0.5% | 12.7% | ||
| Q3 24 | 0.1% | 10.2% | ||
| Q2 24 | 0.1% | 7.3% | ||
| Q1 24 | 0.1% | 8.6% |
| Q4 25 | — | 3.89× | ||
| Q3 25 | — | 3.54× | ||
| Q2 25 | — | 2.15× | ||
| Q1 25 | — | 2.23× | ||
| Q4 24 | — | 1.72× | ||
| Q3 24 | — | 2.54× | ||
| Q2 24 | 6.04× | 1.64× | ||
| Q1 24 | — | 3.25× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLOV
Segment breakdown not available.
ENTG
| Fabs | $516.3M | 63% |
| Equipment And Engineering | $121.8M | 15% |
| Chemical And Materials | $83.8M | 10% |
| Other | $61.7M | 7% |
| Non Semi | $40.3M | 5% |
